Participants (N=3417) were randomly assigned (21:3:3:7) to receive the combination of semaglutide 2.4 mg and cagrilintide 2.4 mg (n=2108), semaglutide 2.4 mg alone (n=302), cagrilintide 2.4 mg alone (n=302), or placebo (n=705), plus lifestyle interventions for all groups
-Amber R
En medicina funcional, cuando un mecanismo no es definitivo, trabajamos con dos reglas: 1) no prometer ms de lo que la evidencia permite y 2) priorizar seguridad, contexto y seguimiento
Duan, M., Yang, M., Li, C., et al
The drugs that were imported from China were unapproved peptides and weight loss drugs labeled for research purposes only. Products bearing this label are not intended to be used by humans, but bad actors use them as a legal loophole to sell consumers unapproved drugs